Clinical trial
Post - Marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients
NCT00909389 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post - Marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients
- Lead sponsor
- Organon and Co
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- November 30, 2008
- Enrollment
- 4,748 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.